Article Versions Notes

Khashab R, Gutman-Sharabi N, Shabtai Z, Landau R, Halperin R, Fay-Karmon T, Leibowitz A, Sharabi Y. Dihydroxyphenylacetaldehyde Lowering Treatment Improves Locomotor and Neurochemical Abnormalities in the Rat Rotenone Model: Relevance to the Catecholaldehyde Hypothesis for the Pathogenesis of Parkinson’s Disease. International Journal of Molecular Sciences. 2023; 24(15):12522. https://doi.org/10.3390/ijms241512522

Khashab, Rawan, Naama Gutman-Sharabi, Zehava Shabtai, Regev Landau, Reut Halperin, Tsviya Fay-Karmon, Avshalom Leibowitz, and Yehonatan Sharabi. 2023. "Dihydroxyphenylacetaldehyde Lowering Treatment Improves Locomotor and Neurochemical Abnormalities in the Rat Rotenone Model: Relevance to the Catecholaldehyde Hypothesis for the Pathogenesis of Parkinson’s Disease" International Journal of Molecular Sciences 24, no. 15: 12522. https://doi.org/10.3390/ijms241512522

Khashab, R., Gutman-Sharabi, N., Shabtai, Z., Landau, R., Halperin, R., Fay-Karmon, T., Leibowitz, A., & Sharabi, Y. (2023). Dihydroxyphenylacetaldehyde Lowering Treatment Improves Locomotor and Neurochemical Abnormalities in the Rat Rotenone Model: Relevance to the Catecholaldehyde Hypothesis for the Pathogenesis of Parkinson’s Disease. International Journal of Molecular Sciences, 24(15), 12522. https://doi.org/10.3390/ijms241512522